Hurwenen, Netherlands

Adrianus Petrus Antonius De Man

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • AH Hurwenen, NL (2019)
  • Oss, NL (2012 - 2024)
  • Hurwenen, NL (2014 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Introduction

Adrianus Petrus Antonius De Man, based in Hurwenen, Netherlands, is a remarkable inventor known for his significant contributions to pharmaceutical research. With a portfolio of 15 patents, De Man has gained recognition for his innovative work, particularly in the field of cancer treatment.

Latest Patents

Among his latest inventions is a compound identified as (5,6-dihydro)pyrimido[4,5-e]indolizines, which presents a formula wherein R and R are independently selected from a group comprising optionally substituted 6-10 carbon aryl and 1-5 carbon heteroaryl groups. This compound holds promise for use in pharmaceutical compositions, especially for the treatment of cancer. Another notable patent involves developing prognostic biomarkers for TTK inhibitor chemotherapy, offering a method to identify tumors susceptible to TTK inhibitor treatment. This method includes steps such as providing a tumor sample and determining the presence of mutated CTNNB1 genes or proteins, which are crucial indicators for effective treatment.

Career Highlights

Throughout his career, Adrianus De Man has worked with esteemed companies, notably the Netherlands Translational Research Center B.V. and Merck Sharp & Dohme B.V., both of which emphasize the impact of his research in innovative drug development. His extensive work in this realm underscores his role as a pivotal figure in advancing medical therapies.

Collaborations

De Man has collaborated with notable professionals, including Jan Gerard Sterrenburg and Guido Jenny Rudolf Zaman. These partnerships have fostered a collaborative environment that enhances the overall impact of his research, leading to successful innovations in the pharmaceutical landscape.

Conclusion

Adrianus Petrus Antonius De Man exemplifies the spirit of innovation in the pharmaceutical industry. With his impressive array of patents and dedication to advancing cancer treatment, he continues to inspire future generations of inventors and researchers in the field. His work not only highlights the importance of collaboration but also emphasizes the transformative potential of dedicated research in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…